Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

Mise à jour : Il y a 4 ans
Référence : NCT01735344

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a randomized, balanced, open Label, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, male and female human subjects.


Critère d'inclusion

  • Fed

Liens